BDSI

BioDelivery Sciences International, Inc. Press Releases

$7.41
*  
0.01
 negative 
0.14%
Get BDSI Alerts
*Delayed - data as of Apr. 17, 2014 12:27 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BDSI Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference
4/7/2014 9:40:00 AM - PR Newswire

BioDelivery Sciences Announces Enrollment of the First Patient in a Phase 3 Clinical Study of Clonidine Topical Gel for Painful Diabetic Neuropathy
4/3/2014 7:00:00 AM - PR Newswire

Foresite Capital Closes $300 Million Fund II to Finance Late-Stage Healthcare Companies
4/1/2014 8:00:00 AM - Business Wire

BioDelivery Sciences Announces Commercialization Agreement with Quintiles to Support the Launch of BUNAVAIL in the U.S.
3/27/2014 7:00:00 AM - PR Newswire

BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2013 Annual Report
3/14/2014 6:30:00 AM - PR Newswire

Equities Hitting New High: Allergan, Aetna, Ecolab, and BioDelivery Sciences Intl.
3/12/2014 12:17:00 PM - PR Newswire

BioDelivery Sciences to Present at the 26th Annual ROTH Conference
3/5/2014 7:00:00 AM - PR Newswire

BioDelivery Sciences to Present at the Cowen and Company 34th Annual Health Care Conference
2/28/2014 7:00:00 AM - PR Newswire

BioDelivery Sciences Closes $60 Million Registered Direct Offering
2/13/2014 7:00:00 AM - PR Newswire

BioDelivery Sciences to Raise $60 Million in Registered Direct Offering From Institutional Investors
2/10/2014 7:00:00 AM - PR Newswire

BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference
1/30/2014 7:00:00 AM - PR Newswire

Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain
1/23/2014 4:30:00 PM - PR Newswire